Table 2.

Change of average systolic (SBP) and diastolic (DBP) blood pressure in mmHg within the RDT-PEF trial at 3 and 12 months follow-up.

Variables	Baseline			Change at 3 months			Change at 12 months
	RDT (n = 17)	Control (n = 8)	P	RDT (n = 16)	Control (n = 8)	P	RDT (n = 17)	Control (n = 7)	P
Ambulatory blood pressure monitoring (mmHg)
24 h
SBP	126.8 ± 15.9	121.1 ± 7.5	0.349	−1.1 ± 13.2	+0.9 ± 11.2	0.727	−2.4 ± 9.7	+1.3 ± 9.4	0.410
DBP	71.5 ± 9.1	70.0 ± 6.2	0.672	−2.0 ± 7.9	−1.4 ± 6.2	0.847	−2.9 ± 5.8	−1.7 ± 7.4	0.684
PP	55.2 ± 14.3	51.1 ± 7.6	0.457	+1.1 ± 6.3	+2.0 ± 5.9	0.746	+1.2 ± 6.8	+7.1 ± 13.7	0.166
Day (0800–2200)
SBP	128.1 ± 15.9	123.0 ± 7.9	0.400	−1.0 ± 12.7	+1.6 ± 11.4	0.628	−2.7 ± 10.4	+2.1 ± 11.0	0.318
DBP	72.9 ± 10.4	72.3 ± 5.7	0.863	−2.1 ± 7.6	−1.4 ± 7.0	0.817	−3.7 ± 6.7*	−1.9 ± 7.5	0.558
PP	55.2 ± 14.4	50.8 ± 8.2	0.424	+1.0 ± 6.6	+3.3 ± 5.4	0.413	+0.8 ± 7.1	+3.7 ± 6.4	0.360
Night (2200–0800)
SBP	121.2 ± 18.1	113.7 ± 6.7	0.164	+2.0 ± 16.7	−5.9 ± 8.2	0.256	−0.3 ± 12.0	−1.6 ± 9.5	0.800
DBP	67.9 ± 8.0	63.6 ± 6.8	0.225	−0.7 ± 9.9	−3.0 ± 6.9	0.580	−0.1 ± 6.6	−2.7 ± 9.1	0.438
PP	53.6 ± 14.5	50.3 ± 7.3	0.480	+2.5 ± 8.0	−2.9 ± 3.6	0.111	−0.5 ± 6.9	+0.7 ± 3.5	0.669

^*P < 0.05 for within group change.